Eli Lilly and Company

🇺🇸New York Stock Exchange
Back to all articles
Eli Lilly and Company stock analysis LLY overview
Bullish +75

Amazon expands access to weight-loss pill with kiosks, same-day delivery

📦 Amazon Pharmacy will stock Eli Lilly's new Foundayo GLP-1 pill at clinic kiosks starting in 2026.

💊 The oral medication offers storage advantages over injectable drugs by not requiring refrigeration.

🚚 Same-day delivery will be available in select areas, expanding beyond the current half of U.S. customers.

⏳ All prescription medications can be delivered within four days regardless of delivery speed tier.

🤝 Amazon Pharmacy is already filling prescriptions for Foundayo launched on Eli Lilly's direct-to-consumer platform.

🏥 The rollout includes kiosks inside One Medical primary care clinics across selected locations.

📍 Kiosk availability beyond California depends on state regulations and compliance requirements.

💵 Prices for the lowest dose of Foundayo start at $149 per month for cash-paying customers via LillyDirect.

🔙 Amazon began delivering oral Wegovy from Novo Nordisk earlier this year at select kiosks.

🚁 This initiative supports Amazon's broader multibillion-dollar investment to expand delivery in rural and underserved areas.

🌐 The strategy aims to improve access to common medications while reducing shipping costs through localized kiosk distribution.

Bullish Signals
  • Amazon is expanding access to Eli Lilly's new GLP-1 weight-loss pill, Foundayo, by stocking it at clinics' One Medical kiosks and offering same-day delivery.
  • The pill does not require refrigeration, which simplifies storage and dispensing compared to injectable drugs and supports broader availability via kiosks.
  • Amazon plans to expand its same-day delivery reach for medications beyond the current half of U.S. customers it already serves.
  • All customers can receive medication within four days through Amazon Pharmacy, even in areas where same-day delivery isn't yet available.
  • Amazon has been delivering GLP-1 medications since 2021 and has begun stocking Novo Nordisk's oral Wegovy pill at select kiosks earlier this year.
  • Amazon Pharmacy fulfills prescriptions from Eli Lilly's direct-to-consumer platform, LillyDirect, making the medication accessible starting at $149 per month for the lowest dose.
  • The initiative is part of a multibillion-dollar investment by Amazon to expand its healthcare and delivery footprint, particularly in rural and underserved areas.
Risk Factors
  • Amazon's expansion into Eli Lilly's Foundayo drug may trigger regulatory scrutiny given the company's history with pharmaceuticals.
  • The kiosk model relies on state regulations that could restrict future expansion beyond California.
  • Same-day delivery remains limited to only half of U.S. customers, potentially reducing market penetration compared to competitors.
Full Analysis
Amazon is significantly expanding access to Eli Lilly’s newly approved weight-loss pill, known as Foundayo, by integrating it into its pharmacy operations and logistical network. According to CNBC, Amazon Pharmacy will begin stocking the medication at kiosks located within select One Medical primary care clinics, while also enabling same-day delivery for customers in specific regions. This strategic expansion leverages the pill's unique advantage over injectable alternatives: it does not require refrigeration. Tanvi Patel, vice president at Amazon Pharmacy, explained that this lack of cold storage needs allows the medication to be safely stored and dispensed directly from kiosks, thereby facilitating broader access for patients. The initiative builds upon Amazon’s existing healthcare efforts, which include delivering GLP-1 medications since 2021 and stocking Novo Nordisk’s oral Wegovy pill at select kiosks earlier in the year. Currently, approximately half of U.S. customers have access to same-day delivery through Amazon Pharmacy, with a stated plan to expand this reach. All customers remain eligible for medication delivery within four days. Eli Lilly launched Foundayo recently via its direct-to-consumer platform, LillyDirect, with pricing starting at $149 per month for the lowest dose for cash-paying customers; Amazon Pharmacy will handle prescription fulfillment and partner with organizations like WeightWatchers for delivery options. Amazon introduced its pharmacy kiosks previously to improve medication access and reduce shipping costs, noting that this new rollout is subject to state regulations, with current operations primarily focused on California. Tanvi Patel indicated that kiosk locations are planned to expand beyond the state as regulatory frameworks allow. This move represents a key component of Amazon’s broader push to grow its healthcare footprint and delivery services, including investments aimed at accelerating delivery capabilities in rural and underserved areas. The collaboration highlights an increasing focus on convenient oral therapies that bypass the complexities associated with storing injectable GLP-1 drugs.